Chandrabali Ghose BS, MS, PhD

Chandra received her undergraduate education in Biology and Theology from Saint Louis University, splitting her time between the Madrid, Spain and Saint Louis, Missouri campuses. Subsequently, she moved to New York University where she earned her PhD in Basic Biomedical Sciences from the Department of Microbiology.
Chandra completed her postdoctoral training at Harvard Medical School, before joining the laboratory of Dr. David D. Ho at the Aaron Diamond AIDS Research Center, Rockefeller University. She ran the Clostridium difficile vaccine and therapeutics program as a Research Scientist till 2015. Before she started Bioharmony Therapeutics in July of 2016, Chandra was the CSO of Symbiotic Health, a startup focused on the development of therapies for Clostridium difficile infections.